S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 212 SEK -0.47%
Market Cap: 1.9B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stille AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Gross Profit
kr239.7m
CAGR 3-Years
46%
CAGR 5-Years
29%
CAGR 10-Years
24%
Elekta AB (publ)
STO:EKTA B
Gross Profit
kr6.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Gross Profit
kr590.3m
CAGR 3-Years
53%
CAGR 5-Years
53%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Gross Profit
kr493.8m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
14%
Getinge AB
STO:GETI B
Gross Profit
kr14.5B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Gross Profit
kr4.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.9B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
292.37 SEK
Undervaluation 27%
Intrinsic Value
Price
S

See Also

What is Stille AB's Gross Profit?
Gross Profit
239.7m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Gross Profit amounts to 239.7m SEK.

What is Stille AB's Gross Profit growth rate?
Gross Profit CAGR 10Y
24%

Over the last year, the Gross Profit growth was 91%. The average annual Gross Profit growth rates for Stille AB have been 46% over the past three years , 29% over the past five years , and 24% over the past ten years .

Back to Top